Selected research
Market Structure
Global Injectable Anti-aging Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Injectable Anti-aging Product market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Injectable Anti-aging Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Injectable Anti-aging Product include LIBP, Bloomage Bio, Haohai Biological, Beijing IMEIK, AbbVie, US World Meds, Teoxane, Suneva Medical and Sinclair, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Injectable Anti-aging Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Injectable Anti-aging Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Injectable Anti-aging Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Anti-aging Product market size, projected growth trends, production technologies, key applications, and end-use industries.
Injectable Anti-aging Product Segment by Company
LIBP
Bloomage Bio
Haohai Biological
Beijing IMEIK
AbbVie
US World Meds
Teoxane
Suneva Medical
Sinclair
SciVision Biotech
Prollenium
Merz
Medytox
LG Life Sciences
JETEMA
Ipsen
Hugel
Galderma
Elravie (Humedix)
Daewoong
Croma-Pharma
Cleviel (Pharma Research Products)
CG Bio
Caregen
Bohus BioTech
Injectable Anti-aging Product Segment by Type
Botulinum Toxin
Dermal Fillers
Others
Injectable Anti-aging Product Segment by Application
Hospital
Beauty Parlor
Others
Injectable Anti-aging Product Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Anti-aging Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Anti-aging Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Anti-aging Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Injectable Anti-aging Product market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anti-aging Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Anti-aging Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Injectable Anti-aging Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Injectable Anti-aging Product Industry Trends
Table 2. Injectable Anti-aging Product Industry Drivers
Table 3. Injectable Anti-aging Product Industry Opportunities and Challenges
Table 4. Injectable Anti-aging Product Industry Restraints
Table 5. Global Injectable Anti-aging Product Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Injectable Anti-aging Product Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Injectable Anti-aging Product Sales by Manufacturers (k units) & (2021-2026)
Table 8. Global Injectable Anti-aging Product Sales Market Share by Manufacturers
Table 9. Global Injectable Anti-aging Product Average Sales Price (USD/unit) of Manufacturers (2021-2026)
Table 10. Global Injectable Anti-aging Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Injectable Anti-aging Product Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Injectable Anti-aging Product Manufacturers, Product Type & Application
Table 13. Global Injectable Anti-aging Product Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Injectable Anti-aging Product by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Botulinum Toxin
Table 17. Major Manufacturers of Dermal Fillers
Table 18. Major Manufacturers of Others
Table 19. Global Injectable Anti-aging Product Sales by Type 2021 VS 2025 VS 2032 (k units)
Table 20. Global Injectable Anti-aging Product Sales by Type (2021-2026) & (k units)
Table 21. Global Injectable Anti-aging Product Sales by Type (2027-2032) & (k units)
Table 22. Global Injectable Anti-aging Product Sales Market Share by Type (2021-2026)
Table 23. Global Injectable Anti-aging Product Sales Market Share by Type (2027-2032)
Table 24. Global Injectable Anti-aging Product Revenue by Type 2021 VS 2025 VS 2032 (k units)
Table 25. Global Injectable Anti-aging Product Revenue by Type (2021-2026) & (k units)
Table 26. Global Injectable Anti-aging Product Revenue by Type (2027-2032) & (k units)
Table 27. Global Injectable Anti-aging Product Revenue Market Share by Type (2021-2026)
Table 28. Global Injectable Anti-aging Product Revenue Market Share by Type (2027-2032)
Table 29. Major Manufacturers of Hospital
Table 30. Major Manufacturers of Beauty Parlor
Table 31. Major Manufacturers of Others
Table 32. Global Injectable Anti-aging Product Sales by Application 2021 VS 2025 VS 2032 (k units)
Table 33. Global Injectable Anti-aging Product Sales by Application (2021-2026) & (k units)
Table 34. Global Injectable Anti-aging Product Sales by Application (2027-2032) & (k units)
Table 35. Global Injectable Anti-aging Product Sales Market Share by Application (2021-2026)
Table 36. Global Injectable Anti-aging Product Sales Market Share by Application (2027-2032)
Table 37. Global Injectable Anti-aging Product Revenue by Application 2021 VS 2025 VS 2032 (k units)
Table 38. Global Injectable Anti-aging Product Revenue by Application (2021-2026) & (k units)
Table 39. Global Injectable Anti-aging Product Revenue by Application (2027-2032) & (k units)
Table 40. Global Injectable Anti-aging Product Revenue Market Share by Application (2021-2026)
Table 41. Global Injectable Anti-aging Product Revenue Market Share by Application (2027-2032)
Table 42. Global Injectable Anti-aging Product Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 43. Global Injectable Anti-aging Product Sales by Region (2021-2026) & (k units)
Table 44. Global Injectable Anti-aging Product Sales Market Share by Region (2021-2026)
Table 45. Global Injectable Anti-aging Product Sales Forecasted by Region (2027-2032) & (k units)
Table 46. Global Injectable Anti-aging Product Sales Forecasted Market Share by Region (2027-2032)
Table 47. North America Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 48. North America Injectable Anti-aging Product Sales by Country (2021-2026) & (k units)
Table 49. North America Injectable Anti-aging Product Sales by Country (2027-2032) & (k units)
Table 50. Europe Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 51. Europe Injectable Anti-aging Product Sales by Country (2021-2026) & (k units)
Table 52. Europe Injectable Anti-aging Product Sales by Country (2027-2032) & (k units)
Table 53. Asia Pacific Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 54. Asia Pacific Injectable Anti-aging Product Sales by Country (2021-2026) & (k units)
Table 55. Asia Pacific Injectable Anti-aging Product Sales by Country (2027-2032) & (k units)
Table 56. South America, Middle East and Africa Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 57. South America, Middle East and Africa Injectable Anti-aging Product Sales by Country (2021-2026) & (k units)
Table 58. South America, Middle East and Africa Injectable Anti-aging Product Sales by Country (2027-2032) & (k units)
Table 59. Global Injectable Anti-aging Product Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 60. Global Injectable Anti-aging Product Revenue by Region (2021-2026) & (US$ Million)
Table 61. Global Injectable Anti-aging Product Revenue by Region (2027-2032) & (US$ Million)
Table 62. Global Injectable Anti-aging Product Revenue Market Share by Region (2021-2026)
Table 63. Global Injectable Anti-aging Product Revenue Market Share by Region (2027-2032)
Table 64. LIBP Company Information
Table 65. LIBP Business Overview
Table 66. LIBP Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. LIBP Injectable Anti-aging Product Product Portfolio
Table 68. LIBP Recent Development
Table 69. Bloomage Bio Company Information
Table 70. Bloomage Bio Business Overview
Table 71. Bloomage Bio Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. Bloomage Bio Injectable Anti-aging Product Product Portfolio
Table 73. Bloomage Bio Recent Development
Table 74. Haohai Biological Company Information
Table 75. Haohai Biological Business Overview
Table 76. Haohai Biological Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. Haohai Biological Injectable Anti-aging Product Product Portfolio
Table 78. Haohai Biological Recent Development
Table 79. Beijing IMEIK Company Information
Table 80. Beijing IMEIK Business Overview
Table 81. Beijing IMEIK Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. Beijing IMEIK Injectable Anti-aging Product Product Portfolio
Table 83. Beijing IMEIK Recent Development
Table 84. AbbVie Company Information
Table 85. AbbVie Business Overview
Table 86. AbbVie Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. AbbVie Injectable Anti-aging Product Product Portfolio
Table 88. AbbVie Recent Development
Table 89. US World Meds Company Information
Table 90. US World Meds Business Overview
Table 91. US World Meds Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 92. US World Meds Injectable Anti-aging Product Product Portfolio
Table 93. US World Meds Recent Development
Table 94. Teoxane Company Information
Table 95. Teoxane Business Overview
Table 96. Teoxane Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 97. Teoxane Injectable Anti-aging Product Product Portfolio
Table 98. Teoxane Recent Development
Table 99. Suneva Medical Company Information
Table 100. Suneva Medical Business Overview
Table 101. Suneva Medical Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 102. Suneva Medical Injectable Anti-aging Product Product Portfolio
Table 103. Suneva Medical Recent Development
Table 104. Sinclair Company Information
Table 105. Sinclair Business Overview
Table 106. Sinclair Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 107. Sinclair Injectable Anti-aging Product Product Portfolio
Table 108. Sinclair Recent Development
Table 109. SciVision Biotech Company Information
Table 110. SciVision Biotech Business Overview
Table 111. SciVision Biotech Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 112. SciVision Biotech Injectable Anti-aging Product Product Portfolio
Table 113. SciVision Biotech Recent Development
Table 114. Prollenium Company Information
Table 115. Prollenium Business Overview
Table 116. Prollenium Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 117. Prollenium Injectable Anti-aging Product Product Portfolio
Table 118. Prollenium Recent Development
Table 119. Merz Company Information
Table 120. Merz Business Overview
Table 121. Merz Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 122. Merz Injectable Anti-aging Product Product Portfolio
Table 123. Merz Recent Development
Table 124. Medytox Company Information
Table 125. Medytox Business Overview
Table 126. Medytox Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 127. Medytox Injectable Anti-aging Product Product Portfolio
Table 128. Medytox Recent Development
Table 129. LG Life Sciences Company Information
Table 130. LG Life Sciences Business Overview
Table 131. LG Life Sciences Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 132. LG Life Sciences Injectable Anti-aging Product Product Portfolio
Table 133. LG Life Sciences Recent Development
Table 134. JETEMA Company Information
Table 135. JETEMA Business Overview
Table 136. JETEMA Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 137. JETEMA Injectable Anti-aging Product Product Portfolio
Table 138. JETEMA Recent Development
Table 139. Ipsen Company Information
Table 140. Ipsen Business Overview
Table 141. Ipsen Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 142. Ipsen Injectable Anti-aging Product Product Portfolio
Table 143. Ipsen Recent Development
Table 144. Hugel Company Information
Table 145. Hugel Business Overview
Table 146. Hugel Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 147. Hugel Injectable Anti-aging Product Product Portfolio
Table 148. Hugel Recent Development
Table 149. Galderma Company Information
Table 150. Galderma Business Overview
Table 151. Galderma Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 152. Galderma Injectable Anti-aging Product Product Portfolio
Table 153. Galderma Recent Development
Table 154. Elravie (Humedix) Company Information
Table 155. Elravie (Humedix) Business Overview
Table 156. Elravie (Humedix) Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 157. Elravie (Humedix) Injectable Anti-aging Product Product Portfolio
Table 158. Elravie (Humedix) Recent Development
Table 159. Daewoong Company Information
Table 160. Daewoong Business Overview
Table 161. Daewoong Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 162. Daewoong Injectable Anti-aging Product Product Portfolio
Table 163. Daewoong Recent Development
Table 164. Croma-Pharma Company Information
Table 165. Croma-Pharma Business Overview
Table 166. Croma-Pharma Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 167. Croma-Pharma Injectable Anti-aging Product Product Portfolio
Table 168. Croma-Pharma Recent Development
Table 169. Cleviel (Pharma Research Products) Company Information
Table 170. Cleviel (Pharma Research Products) Business Overview
Table 171. Cleviel (Pharma Research Products) Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 172. Cleviel (Pharma Research Products) Injectable Anti-aging Product Product Portfolio
Table 173. Cleviel (Pharma Research Products) Recent Development
Table 174. CG Bio Company Information
Table 175. CG Bio Business Overview
Table 176. CG Bio Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 177. CG Bio Injectable Anti-aging Product Product Portfolio
Table 178. CG Bio Recent Development
Table 179. Caregen Company Information
Table 180. Caregen Business Overview
Table 181. Caregen Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 182. Caregen Injectable Anti-aging Product Product Portfolio
Table 183. Caregen Recent Development
Table 184. Bohus BioTech Company Information
Table 185. Bohus BioTech Business Overview
Table 186. Bohus BioTech Injectable Anti-aging Product Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 187. Bohus BioTech Injectable Anti-aging Product Product Portfolio
Table 188. Bohus BioTech Recent Development
Table 189. Key Raw Materials
Table 190. Raw Materials Key Suppliers
Table 191. Injectable Anti-aging Product Distributors List
Table 192. Injectable Anti-aging Product Customers List
Table 193. Research Programs/Design for This Report
Table 194. Authors List of This Report
Table 195. Secondary Sources
Table 196. Primary Sources
List of Figures
Figure 1. Injectable Anti-aging Product Product Image
Figure 2. Global Injectable Anti-aging Product Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Injectable Anti-aging Product Market Size (2021-2032) & (US$ Million)
Figure 4. Global Injectable Anti-aging Product Sales (2021-2032) & (k units)
Figure 5. Global Injectable Anti-aging Product Average Price (USD/unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Injectable Anti-aging Product Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Botulinum Toxin Image
Figure 9. Dermal Fillers Image
Figure 10. Others Image
Figure 11. Global Injectable Anti-aging Product Sales by Type (2021 VS 2025 VS 2032) & (k units)
Figure 12. Global Injectable Anti-aging Product Sales Market Share 2021 VS 2025 VS 2032
Figure 13. Global Injectable Anti-aging Product Sales Market Share by Type (2021-2032)
Figure 14. Global Injectable Anti-aging Product Revenue by Type (2021 VS 2025 VS 2032) & (k units)
Figure 15. Global Injectable Anti-aging Product Revenue Market Share 2021 VS 2025 VS 2032
Figure 16. Global Injectable Anti-aging Product Revenue Market Share by Type (2021-2032)
Figure 17. Hospital Image
Figure 18. Beauty Parlor Image
Figure 19. Others Image
Figure 20. Global Injectable Anti-aging Product Sales by Application (2021 VS 2025 VS 2032) & (k units)
Figure 21. Global Injectable Anti-aging Product Sales Market Share 2021 VS 2025 VS 2032
Figure 22. Global Injectable Anti-aging Product Sales Market Share by Application (2021-2032)
Figure 23. Global Injectable Anti-aging Product Revenue by Application (2021 VS 2025 VS 2032) & (k units)
Figure 24. Global Injectable Anti-aging Product Revenue Market Share 2021 VS 2025 VS 2032
Figure 25. Global Injectable Anti-aging Product Revenue Market Share by Application (2021-2032)
Figure 26. North America Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 27. North America Injectable Anti-aging Product Sales Market Share by Country (2021-2032)
Figure 28. U.S. Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 29. Canada Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 30. Mexico Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 31. Europe Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 32. Europe Injectable Anti-aging Product Sales Market Share by Country (2021-2032)
Figure 33. Germany Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 34. France Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 35. U.K. Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 36. Italy Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 37. Netherlands Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 38. Asia Pacific Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 39. Asia Pacific Injectable Anti-aging Product Sales Market Share by Country (2021-2032)
Figure 40. China Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 41. Japan Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 42. South Korea Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 43. Southeast Asia Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 44. India Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 45. Australia Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 46. South America, Middle East and Africa Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 47. South America, Middle East and Africa Injectable Anti-aging Product Sales Market Share by Country (2021-2032)
Figure 48. Brazil Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 49. South Africa Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 50. Saudi Arabia Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 51. Turkey Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 52. Argentina Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 53. UAE Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 54. Egypt Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 55. Chile Injectable Anti-aging Product Sales and Growth Rate (2021-2032) & (k units)
Figure 56. Global Injectable Anti-aging Product Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 57. Global Injectable Anti-aging Product Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 58. North America Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million)
Figure 59. North America Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 60. Europe Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million)
Figure 61. Europe Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 62. Asia-Pacific Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million)
Figure 63. Asia-Pacific Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 64. South America, Middle East and Africa Injectable Anti-aging Product Revenue (2021-2032) & (US$ Million)
Figure 65. South America, Middle East and Africa Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 66. Injectable Anti-aging Product Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Injectable Anti-aging Product Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
Scope & coverage.
Types
- Botulinum Toxin
- Dermal Fillers
- Others
Applications
- Hospital
- Beauty Parlor
- Others
Companies covered
- LIBP
- Bloomage Bio
- Haohai Biological
- Beijing IMEIK
- AbbVie
- US World Meds
- Teoxane
- Suneva Medical
- Sinclair
- SciVision Biotech
- Prollenium
- Merz
- Medytox
- LG Life Sciences
- JETEMA
- Ipsen
- Hugel
- Galderma
- Elravie (Humedix)
- Daewoong
- Croma-Pharma
- Cleviel (Pharma Research Products)
- CG Bio
- Caregen
- Bohus BioTech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Injectable Anti-aging Product Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Injectable Anti-aging Product Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Injectable Anti-aging Product Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Injectable Anti-aging Product Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Injectable Anti-aging Product Market Dynamics
- 2.1 Injectable Anti-aging Product Industry Trends
- 2.2 Injectable Anti-aging Product Industry Drivers
- 2.3 Injectable Anti-aging Product Industry Opportunities and Challenges
- 2.4 Injectable Anti-aging Product Industry Restraints
3 Injectable Anti-aging Product Market by Manufacturers
- 3.1 Global Injectable Anti-aging Product Revenue by Manufacturers (2021-2026)
- 3.2 Global Injectable Anti-aging Product Sales by Manufacturers (2021-2026)
- 3.3 Global Injectable Anti-aging Product Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Injectable Anti-aging Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Injectable Anti-aging Product Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Injectable Anti-aging Product Manufacturers, Product Type & Application
- 3.7 Global Injectable Anti-aging Product Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Injectable Anti-aging Product Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Injectable Anti-aging Product Players Market Share by Revenue in 2025
- 3.8.3 2025 Injectable Anti-aging Product Tier 1, Tier 2, and Tier 3
4 Injectable Anti-aging Product Market by Type
- 4.1 Injectable Anti-aging Product Type Introduction
- 4.1.1 Botulinum Toxin
- 4.1.2 Dermal Fillers
- 4.1.3 Others
- 4.2 Global Injectable Anti-aging Product Sales by Type
- 4.2.1 Global Injectable Anti-aging Product Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Injectable Anti-aging Product Sales by Type (2021-2032)
- 4.2.3 Global Injectable Anti-aging Product Sales Market Share by Type (2021-2032)
- 4.3 Global Injectable Anti-aging Product Revenue by Type
- 4.3.1 Global Injectable Anti-aging Product Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Injectable Anti-aging Product Revenue by Type (2021-2032)
- 4.3.3 Global Injectable Anti-aging Product Revenue Market Share by Type (2021-2032)
5 Injectable Anti-aging Product Market by Application
- 5.1 Injectable Anti-aging Product Application Introduction
- 5.1.1 Hospital
- 5.1.2 Beauty Parlor
- 5.1.3 Others
- 5.2 Global Injectable Anti-aging Product Sales by Application
- 5.2.1 Global Injectable Anti-aging Product Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Injectable Anti-aging Product Sales by Application (2021-2032)
- 5.2.3 Global Injectable Anti-aging Product Sales Market Share by Application (2021-2032)
- 5.3 Global Injectable Anti-aging Product Revenue by Application
- 5.3.1 Global Injectable Anti-aging Product Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Injectable Anti-aging Product Revenue by Application (2021-2032)
- 5.3.3 Global Injectable Anti-aging Product Revenue Market Share by Application (2021-2032)
6 Global Injectable Anti-aging Product Sales by Region
- 6.1 Global Injectable Anti-aging Product Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Injectable Anti-aging Product Sales by Region (2021-2032)
- 6.2.1 Global Injectable Anti-aging Product Sales by Region (2021-2026)
- 6.2.2 Global Injectable Anti-aging Product Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Injectable Anti-aging Product Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Injectable Anti-aging Product Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Injectable Anti-aging Product Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Injectable Anti-aging Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Injectable Anti-aging Product Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Injectable Anti-aging Product Revenue by Region
- 7.1 Global Injectable Anti-aging Product Revenue by Region
- 7.1.1 Global Injectable Anti-aging Product Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Injectable Anti-aging Product Revenue by Region (2021-2026)
- 7.1.3 Global Injectable Anti-aging Product Revenue by Region (2027-2032)
- 7.1.4 Global Injectable Anti-aging Product Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Injectable Anti-aging Product Revenue (2021-2032)
- 7.2.2 North America Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Injectable Anti-aging Product Revenue (2021-2032)
- 7.3.2 Europe Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Injectable Anti-aging Product Revenue (2021-2032)
- 7.4.2 Asia-Pacific Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Injectable Anti-aging Product Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Injectable Anti-aging Product Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 LIBP
- 8.1.1 LIBP Company Information
- 8.1.2 LIBP Business Overview
- 8.1.3 LIBP Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 LIBP Injectable Anti-aging Product Product Portfolio
- 8.1.5 LIBP Recent Developments
- 8.2 Bloomage Bio
- 8.2.1 Bloomage Bio Company Information
- 8.2.2 Bloomage Bio Business Overview
- 8.2.3 Bloomage Bio Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bloomage Bio Injectable Anti-aging Product Product Portfolio
- 8.2.5 Bloomage Bio Recent Developments
- 8.3 Haohai Biological
- 8.3.1 Haohai Biological Company Information
- 8.3.2 Haohai Biological Business Overview
- 8.3.3 Haohai Biological Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Haohai Biological Injectable Anti-aging Product Product Portfolio
- 8.3.5 Haohai Biological Recent Developments
- 8.4 Beijing IMEIK
- 8.4.1 Beijing IMEIK Company Information
- 8.4.2 Beijing IMEIK Business Overview
- 8.4.3 Beijing IMEIK Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Beijing IMEIK Injectable Anti-aging Product Product Portfolio
- 8.4.5 Beijing IMEIK Recent Developments
- 8.5 AbbVie
- 8.5.1 AbbVie Company Information
- 8.5.2 AbbVie Business Overview
- 8.5.3 AbbVie Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 AbbVie Injectable Anti-aging Product Product Portfolio
- 8.5.5 AbbVie Recent Developments
- 8.6 US World Meds
- 8.6.1 US World Meds Company Information
- 8.6.2 US World Meds Business Overview
- 8.6.3 US World Meds Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 US World Meds Injectable Anti-aging Product Product Portfolio
- 8.6.5 US World Meds Recent Developments
- 8.7 Teoxane
- 8.7.1 Teoxane Company Information
- 8.7.2 Teoxane Business Overview
- 8.7.3 Teoxane Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Teoxane Injectable Anti-aging Product Product Portfolio
- 8.7.5 Teoxane Recent Developments
- 8.8 Suneva Medical
- 8.8.1 Suneva Medical Company Information
- 8.8.2 Suneva Medical Business Overview
- 8.8.3 Suneva Medical Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Suneva Medical Injectable Anti-aging Product Product Portfolio
- 8.8.5 Suneva Medical Recent Developments
- 8.9 Sinclair
- 8.9.1 Sinclair Company Information
- 8.9.2 Sinclair Business Overview
- 8.9.3 Sinclair Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sinclair Injectable Anti-aging Product Product Portfolio
- 8.9.5 Sinclair Recent Developments
- 8.10 SciVision Biotech
- 8.10.1 SciVision Biotech Company Information
- 8.10.2 SciVision Biotech Business Overview
- 8.10.3 SciVision Biotech Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 SciVision Biotech Injectable Anti-aging Product Product Portfolio
- 8.10.5 SciVision Biotech Recent Developments
- 8.11 Prollenium
- 8.11.1 Prollenium Company Information
- 8.11.2 Prollenium Business Overview
- 8.11.3 Prollenium Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Prollenium Injectable Anti-aging Product Product Portfolio
- 8.11.5 Prollenium Recent Developments
- 8.12 Merz
- 8.12.1 Merz Company Information
- 8.12.2 Merz Business Overview
- 8.12.3 Merz Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Merz Injectable Anti-aging Product Product Portfolio
- 8.12.5 Merz Recent Developments
- 8.13 Medytox
- 8.13.1 Medytox Company Information
- 8.13.2 Medytox Business Overview
- 8.13.3 Medytox Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Medytox Injectable Anti-aging Product Product Portfolio
- 8.13.5 Medytox Recent Developments
- 8.14 LG Life Sciences
- 8.14.1 LG Life Sciences Company Information
- 8.14.2 LG Life Sciences Business Overview
- 8.14.3 LG Life Sciences Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 LG Life Sciences Injectable Anti-aging Product Product Portfolio
- 8.14.5 LG Life Sciences Recent Developments
- 8.15 JETEMA
- 8.15.1 JETEMA Company Information
- 8.15.2 JETEMA Business Overview
- 8.15.3 JETEMA Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 JETEMA Injectable Anti-aging Product Product Portfolio
- 8.15.5 JETEMA Recent Developments
- 8.16 Ipsen
- 8.16.1 Ipsen Company Information
- 8.16.2 Ipsen Business Overview
- 8.16.3 Ipsen Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Ipsen Injectable Anti-aging Product Product Portfolio
- 8.16.5 Ipsen Recent Developments
- 8.17 Hugel
- 8.17.1 Hugel Company Information
- 8.17.2 Hugel Business Overview
- 8.17.3 Hugel Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Hugel Injectable Anti-aging Product Product Portfolio
- 8.17.5 Hugel Recent Developments
- 8.18 Galderma
- 8.18.1 Galderma Company Information
- 8.18.2 Galderma Business Overview
- 8.18.3 Galderma Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Galderma Injectable Anti-aging Product Product Portfolio
- 8.18.5 Galderma Recent Developments
- 8.19 Elravie (Humedix)
- 8.19.1 Elravie (Humedix) Company Information
- 8.19.2 Elravie (Humedix) Business Overview
- 8.19.3 Elravie (Humedix) Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Elravie (Humedix) Injectable Anti-aging Product Product Portfolio
- 8.19.5 Elravie (Humedix) Recent Developments
- 8.20 Daewoong
- 8.20.1 Daewoong Company Information
- 8.20.2 Daewoong Business Overview
- 8.20.3 Daewoong Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Daewoong Injectable Anti-aging Product Product Portfolio
- 8.20.5 Daewoong Recent Developments
- 8.21 Croma-Pharma
- 8.21.1 Croma-Pharma Company Information
- 8.21.2 Croma-Pharma Business Overview
- 8.21.3 Croma-Pharma Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Croma-Pharma Injectable Anti-aging Product Product Portfolio
- 8.21.5 Croma-Pharma Recent Developments
- 8.22 Cleviel (Pharma Research Products)
- 8.22.1 Cleviel (Pharma Research Products) Company Information
- 8.22.2 Cleviel (Pharma Research Products) Business Overview
- 8.22.3 Cleviel (Pharma Research Products) Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Cleviel (Pharma Research Products) Injectable Anti-aging Product Product Portfolio
- 8.22.5 Cleviel (Pharma Research Products) Recent Developments
- 8.23 CG Bio
- 8.23.1 CG Bio Company Information
- 8.23.2 CG Bio Business Overview
- 8.23.3 CG Bio Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 CG Bio Injectable Anti-aging Product Product Portfolio
- 8.23.5 CG Bio Recent Developments
- 8.24 Caregen
- 8.24.1 Caregen Company Information
- 8.24.2 Caregen Business Overview
- 8.24.3 Caregen Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 Caregen Injectable Anti-aging Product Product Portfolio
- 8.24.5 Caregen Recent Developments
- 8.25 Bohus BioTech
- 8.25.1 Bohus BioTech Company Information
- 8.25.2 Bohus BioTech Business Overview
- 8.25.3 Bohus BioTech Injectable Anti-aging Product Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.25.4 Bohus BioTech Injectable Anti-aging Product Product Portfolio
- 8.25.5 Bohus BioTech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Injectable Anti-aging Product Value Chain Analysis
- 9.1.1 Injectable Anti-aging Product Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Injectable Anti-aging Product Production Mode & Process
- 9.2 Injectable Anti-aging Product Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Injectable Anti-aging Product Distributors
- 9.2.3 Injectable Anti-aging Product Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst